Expression of pp32 gene family members in breast cancer

Breast Cancer Research and Treatment

Volumn 68, Issue 1, 2001, Pages 65-73

  Kadkol, S S ^a   Naga, G A E ^a   Brody, J R ^a   Bai, J ^a   Gusev, Y ^b   Dooley, W C ^b   Pasternack, G R ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Gene expression; pp32

Indexed keywords

MESSENGER RNA; PROTEIN; PROTEIN PP32; PROTEIN PP32R1; PROTEIN PP32R2; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER INFILTRATION; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MOLECULAR CLONING; MULTIGENE FAMILY; ONCOGENE; PILOT STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROBE; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; MULTIGENE FAMILY; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PILOT PROJECTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM;

EID: 0034803580     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1017919507109     Document Type: Article

References (22)

1. Cancer statistics
2. Molecular pathology of breast cancer and its application to clinical management
3. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
4. Critical determination of the frequency of c-erbB2 amplification in breast cancer
5. The clinical significance of epidermal growth factor receptor in breast cancer: A review of 5232 patients
6. Mutations in the p53 gene in primary human breast cancers
7. Expression of p53 protein in infiltrating and in situ breast carcinomas
8. The BRCA1 and BRCA2 breast cancer genes
9. A strong candidate for the breast and ovarian cancer suceptibility gene BRCA1
10. Identification of the breast cancer susceptibility gene BRCA2
11. Modulation of oncogenic potential by alternative gene use in human prostate cancer
12. Localization of the gene encoding the putative human HLA class II-associated protein (PHAPI) to chromosome 15q22.3-q23 by fluorescence in situ hybridization
13. A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal
14. Structure of pp32, an acidic nuclear protein which inhibits oncogene-induced formation of transformed foci
15. Identification of sequences required for inhibition of oncogene mediated transformation by pp32
16. Novel nuclear phosphoprotein pp32 is highly expressed in intermediate- and high-grade prostate cancer
17. Protein phosphatase 2A: A panoply of enzymes
18. Distinct roles for PP1 and PP2A in phosphorylation of the retinoblastoma protein. PP2A regulates the activities of G(1) cyclin-dependent kinases
19. Molecular identification of I1PP2A, a novel potent heat-stable inhibitor protein of protein phosphatase 2A
20. Tumor suppression and potentiation by manipulation of pp32 expression
21. Protein ligands to HuR modulate its interaction with target mRNAs in vivo
22. Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the Set oncoprotein